Carcinogenesis, Vol. 20, No. 7, 1357-1362,
July 1999
© 1999 Oxford University Press
Carcinogenesis |
Effect of mitogenic or regenerative cell proliferation on lacz mutant frequency in the liver of MutaTMMice treated with 5,9-dimethyldibenzo[c,g]carbazole
1 Rhône-Poulenc Rorer, Non-Clinical Safety Assessment, 13 quai Jules Guesde, BP14 94403 Vitry-sur-Seine Cedex,
2 CNRS UPR 42, 94801 Villejuif and
3 Institut Curie-Recherche, Centre Universitaire, 91405 Orsay Cedex, France
The purpose of this work was to investigate the impact of cell proliferation on liver mutagenesis. The genotoxic hepatocarcinogen 5,9-dimethyldibenzo[c,g]carbazole (DMDBC) was administered to lacZ transgenic MutaTMMice at a non-hepatotoxic dose of 10 mg/kg, which induces only a slight increase in the liver lacZ mutant frequency (MF). To determine if cell proliferation stimuli enhanced DMDBC mutagenicity, MF was analyzed in mice first receiving DMDBC 10 mg/kg, then ~2 weeks later, either carbon tetrachloride (CCl4, a cytotoxic agent inducing regenerative cell proliferation) or phenobarbital (PB, a mitogenic agent inducing direct hyperplasia). In preliminary studies, the extent of cell proliferation induced by CCl4, PB and DMDBC was determined in non-transgenic CD2F1 mice by means of 5-bromodeoxyuridine labeling. The labeling index was significantly increased after CCl4 and PB, while no change was detected with DMDBC. MF was then determined in MutaTMMice 28 days after initial DMDBC treatment. No increase in MF was detected in mice receiving CCl4 or PB alone. A 2- to 3-fold increase in MF was detected in mice treated with 10 mg/kg DMDBC alone. In contrast, MF was markedly increased in mice receiving DMDBC followed by proliferative treatment (15-fold with CCl4 and 25-fold with PB). These results demonstrate that expression of DMDBC-induced mutations in mouse liver largely depends on the induction of cell proliferation (by a cytotoxic or mitogenic stimulus) and illustrate that MutaTMMouse is a valuable tool to investigate the early events of liver carcinogenesis.
Abbreviations: BrdU, 5-bromodeoxyuridine; CCl4, carbon tetrachloride; DMDBC, 5,9-dimethyl-dibenzo[c,g]carbazole; LI, labeling index; LW, liver weight; MF, mutant frequency; PB, phenobarbital; p.f.u., plaque-forming units.
4 To whom correspondence should be addressed Email: veronique.thybaud{at}rp-rorer.fr
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  J. A. Ross, T. Moore, and S. A. Leavitt In vivo mutagenicity of conazole fungicides correlates with tumorigenicity Mutagenesis, March 1, 2009; 24(2): 149 - 152. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 I. Martin-Burriel, N. O. Roome, O. Dorchies, and A. Prenez Histopathological and Molecular Changes During Apoptosis Produced by 7H-Dibenzo[c,g]-Carbazole in Mouse Liver Toxicol Pathol, February 1, 2004; 32(2): 202 - 211. [Abstract] [PDF]
|
|
|
|
|
|
O. Dorchies, O. Perin-Roussel, O. Gillardeaux, J.-A. Vericat, N. O. Roome, A. Prenez, and F. Perin Induction of DNA Synthesis in Mouse Liver Following Increases of DNA Adduct Levels Elicited by Very Low Cumulative Doses of the Genotoxic Hepatocarcinogen 7H-dibenzo[c,g]carbazole Toxicol Pathol, August 1, 2001; 29(5): 528 - 534. [Abstract] [PDF]
|
|